Anti-COVID drug 2-deoxy-D-glucose (2-DG) Developed by DRDO DCGI approves anti-COVID drug developed by DRDO for emergency use, the drug comes in powder form in a sachet, which is taken orally by dissolving it in water About Anti COVID drug 2-DG An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories (DRL), Hyderabad. Clinical trial results have shown that this molecule helps in the…
Read MoreAnti-COVID drug 2-deoxy-D-glucose (2-DG) by DRDO
